七月 2026的Immune Tolerance Network市场份额分析

The Immune Tolerance Network’s (ITN) “Learning Early About Peanut” (LEAP) study was the first randomized trial to prevent food allergy in a large cohort of high-risk infants. The results of the study, published in the New England Journal of Medicine and available on TrialShare, demonstrated that consumption of a peanut-containing snack by infants who were at high-risk for developing peanut allergy prevented the subsequent development of allergy.